Cargando…

Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK

PURPOSE: Among a cohort of postmenopausal breast cancer survivors, we aimed to compare the risk of dementia associated with aromatase inhibitor (AI) therapy versus tamoxifen. METHODS: Using UK primary care electronic health records, we identified 14,214 postmenopausal breast cancer survivors (aged ≥...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bromley, Susan E., Matthews, Anthony, Smeeth, Liam, Stanway, Susannah, Bhaskaran, Krishnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776493/ https://www.ncbi.nlm.nih.gov/pubmed/31321612 http://dx.doi.org/10.1007/s11764-019-00782-w

Ejemplares similares

Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
por: Bromley, Susan E., et al.
Publicado: (2019)

Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021)

Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink
por: Chidwick, Kendal, et al.
Publicado: (2018)

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
por: Matthews, Anthony, et al.
Publicado: (2018)

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
por: Strongman, Helen, et al.
Publicado: (2019)

Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom
por: Carreira, Helena, et al.
Publicado: (2020)

Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data
por: Carreira, Helena, et al.
Publicado: (2020)

Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study
por: Strongman, Helen, et al.
Publicado: (2022)

Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink
por: Matthews, Anthony, et al.
Publicado: (2016)

Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study
por: Muzambi, Rutendo, et al.
Publicado: (2021)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
por: Matthews, Anthony, et al.
Publicado: (2016)

Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study
por: Strongman, Helen, et al.
Publicado: (2022)

Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals
por: Strongman, Helen, et al.
Publicado: (2019)

Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors
por: Heery, Mary
Publicado: (2023)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Harrigan, Maura, et al.
Publicado: (2021)

Acute Pericarditis and Cancer Risk: A Matched Cohort Study Using Linked UK Primary and Secondary Care Data
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2018)

Cutaneous sarcoidosis possibly associated with aromatase inhibitors and tamoxifen
por: Sawada, Tomoya, et al.
Publicado: (2023)

Common bacterial infections and risk of incident cognitive decline or dementia: a systematic review protocol
por: Muzambi, Rutendo, et al.
Publicado: (2019)

Partner Bereavement and Detection of Dementia: A UK-Based Cohort Study Using Routine Health Data
por: Forbes, Harriet J., et al.
Publicado: (2019)

Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom
por: Carreira, Helena, et al.
Publicado: (2021)

Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
por: Douglas, Ian J, et al.
Publicado: (2013)

Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)
por: Bhaskaran, Krishnan, et al.
Publicado: (2013)

What is the difference between missing completely at random and missing at random?
por: Bhaskaran, Krishnan, et al.
Publicado: (2014)

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database
por: Bhaskaran, Krishnan, et al.
Publicado: (2012)

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
por: Haque, Reina, et al.
Publicado: (2012)

Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review
por: Muzambi, Rutendo, et al.
Publicado: (2020)

Response to Hulliard, Le Strat, Dubertre, et al.
por: Carreira, Helena, et al.
Publicado: (2019)

Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review
por: Carreira, Helena, et al.
Publicado: (2018)

Completeness and usability of ethnicity data in UK-based primary care and hospital databases
por: Mathur, Rohini, et al.
Publicado: (2014)

Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006–2019: A cohort study
por: Eastwood, Sophie V., et al.
Publicado: (2021)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani, Dimple, et al.
Publicado: (2021)

Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK
por: Bhaskaran, Krishnan, et al.
Publicado: (2018)

Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014
por: Mathur, Rohini, et al.
Publicado: (2017)

Sex-specific risks for cardiovascular disease across the glycaemic spectrum: a population-based cohort study using the UK Biobank
por: Rentsch, Christopher T., et al.
Publicado: (2023)

Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
por: Bhaskaran, Krishnan, et al.
Publicado: (2014)

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
por: Cuzick, J, et al.
Publicado: (2006)

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
por: Dackus, Gwen M H E, et al.
Publicado: (2021)

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
por: Blondon, Marc, et al.
Publicado: (2022)

Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors
por: Hong, Dongsheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0gqt4j7v43bnttrsg5sk0ffiiu